Chimeric antigen receptor–based therapies beyond cancer
Abstract: Adoptive cell transfer (ACT) therapies have gained renewed interest in the field of immunotherapy following the advent of chimeric antigen receptor (CAR) technology. This immunological breakthrough requires immune cell engineering with an artificial surface protein receptor for antigen‐specific recognition coupled to an intracellular protein domain for cell activating functions. CAR‐based ACT has successfully solved some hematological malignancies, and it is expected that other tumors may soon benefit from this approach. However, the potential of CAR technology is such that other immune‐mediated disorders are beginning to profit from it. This review will focus on CAR‐based ACT therapeutic areas other than oncology such as infection, allergy, autoimmunity, transplantation, and fibrotic repair. Herein, we discuss the results and limitations of preclinical and clinical studies in that regard.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Chimeric antigen receptor–based therapies beyond cancer ; day:06 ; month:02 ; year:2023 ; extent:11
European journal of immunology ; (06.02.2023) (gesamt 11)
- Urheber
-
Velasco‐de Andrés, María
Muñoz‐Sánchez, Guillermo
Carrillo‐Serradell, Laura
Gutiérrez‐Hernández, María del Mar
Català, Cristina
Isamat, Marcos
Lozano, Francisco
- DOI
-
10.1002/eji.202250184
- URN
-
urn:nbn:de:101:1-2023020714035114077274
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.09.2025, 16:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Velasco‐de Andrés, María
- Muñoz‐Sánchez, Guillermo
- Carrillo‐Serradell, Laura
- Gutiérrez‐Hernández, María del Mar
- Català, Cristina
- Isamat, Marcos
- Lozano, Francisco
Ähnliche Objekte (12)
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Chimeric Antigen Receptor T-Cell Therapy
Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Chimeric Antigen Receptor T-Cell Therapy
Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Chimeric Antigen Receptor T-Cell Therapy
Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance